Gigavis Signs 46.9 Billion Won Contract to Supply Semiconductor Substrate Inspection Equipment, Equivalent to 89.51% of Last Year's Revenue
Gigavis has signed a 46.9 billion won contract to supply semiconductor substrate inspection equipment with a domestic semiconductor substrate manufacturer. In a regulatory filing on the 23rd, the company stated that the contract amount is 46.937 billion won. This is equivalent to 89.51% of its most

Gigavis has signed a 46.9 billion won contract to supply semiconductor substrate inspection equipment with a domestic semiconductor substrate manufacturer.
In a regulatory filing on the 23rd, the company stated that the contract amount is 46.937 billion won. This is equivalent to 89.51% of its most recent annual revenue of 52.434995936 billion won based on the 2025 consolidated financial statements. The contract amount is the sum of individually issued purchase orders (POs) and does not include value-added tax.
The counterparty is a Korean semiconductor substrate manufacturer. According to the filing, it has no relationship with Gigavis and has a track record of fulfilling similar contracts over the past three years. The sales and supply region is domestic, and the counterparty's specific name was not disclosed at its request for confidentiality.
The contract period runs from October 22, 2026 to December 31, 2027. The start date is the date the purchase order was signed, and the end date is the final delivery deadline stated in the purchase order.
Payment terms consist of a 10% advance payment, 70% interim payment, and 20% final payment. The supply method is in-house production and does not involve outsourced production.
Gigavis explained that the key details of the contract were not disclosed due to the need to protect business confidentiality, and that the contract amount and period may change during the process. The disclosure exemption period lasts until December 31, 2027.
CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.
![[Breaking] GI Innovation Doses First Patient in Phase 2 Trial of GI-301 in Japan, Set to Receive $3.5 Million (Approx. 4.6 Billion Won) in Milestone Payment](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F08%2F602537%2F93bbefb8f7fe9c3f%2Fvariants%2Fhero.webp&w=1920&q=75)
![[Breaking] SK Securities Triggers VI intraday...Share Price Rises 3.62%, Trading Above 2,000-Won Level](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F06%2F579783%2F4e4da2bfb8f012b9%2Fvariants%2Fhero.webp&w=1920&q=75)
![[Wire & Cable Stock Movements] Gaon Cable Down 6.88%, LS Down 5.84%... All 8 Stocks Fall as KOSPI and KOSDAQ Both Weaken](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F06%2F581031%2F0c2a8f5a6d5bef88%2Fvariants%2Fhero.webp&w=1920&q=75)
